13
results
for author:"Kruger A."
in Literature Citations
| Cytochrome P450-dependent metabolism of PCB52 in the nematode Caenorhabditis elegans. Schafer P., Muller M., Kruger A., Steinberg C.E., Menzel R. Arch. Biochem. Biophys. 488:60-68(2009) · Mapped (1) |
| Plasminogen activator inhibitor-2, but not cystatin C, inhibits the prometastatic activity of tissue inhibitor of metalloproteinases-1 in the liver. Kopitz C., Gerg M., Gansbacher B., Kruger A. Hum. Gene Ther. 19:1039-1049(2008) · Mapped (3) |
| Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Vasiljeva O., Korovin M., Gajda M., Brodoefel H., Bojic L., Kruger A., Schurigt U., Sevenich L., Turk B., Peters C. et al. Oncogene 27:4191-4199(2008) · Mapped (3) |
| Distinct functionality of tumor cell-derived gelatinases during formation of liver metastases. Gerg M., Kopitz C., Schaten S., Tschukes A., Kahlert C., Stangl M., von Weyhern C.W., Brucher B.L., Edwards D.R., Brand K. et al. Mol. Cancer Res. 6:341-351(2008) · Mapped (9) |
| Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Zhong J.L., Poghosyan Z., Pennington C.J., Scott X., Handsley M.M., Warn A., Gavrilovic J., Honert K., Kruger A., Span P.N. et al. Mol. Cancer Res. 6:383-394(2008) · Mapped (17) |
| The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Gast D., Riedle S., Issa Y., Pfeifer M., Beckhove P., Sanderson M.P., Arlt M., Moldenhauer G., Fogel M., Kruger A. et al. Oncogene 27:1281-1289(2008) · Mapped (12) |
| Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH. Deng S., Kruger A., Kleschyov A.L., Kalinowski L., Daiber A., Wojnowski L. Free Radic. Biol. Med. 42:466-473(2007) · Mapped (6) |
| Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Vasiljeva O., Papazoglou A., Kruger A., Brodoefel H., Korovin M., Deussing J., Augustin N., Nielsen B.S., Almholt K., Bogyo M. et al. Cancer Res. 66:5242-5250(2006) · Mapped (3) |
| NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Wojnowski L., Kulle B., Schirmer M., Schluter G., Schmidt A., Rosenberger A., Vonhof S., Bickeboller H., Toliat M.R., Suk E.K. et al. Circulation 112:3754-3762(2005) · Mapped (10) |
| The transcriptional landscape of the mammalian genome. Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C. et al. Science 309:1559-1563(2005) · UniProtKB (27,417) · Mapped (5,721) |
| Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Abraham N.G., Rezzani R., Rodella L., Kruger A., Taller D., Li Volti G., Goodman A.I., Kappas A. Am. J. Physiol. Heart Circ. Physiol. 287:H2468-77(2004) · Mapped (4) |
| Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. Hohler T., Kruger A., Gerken G., Schneider P.M., Meyer zum Buschenfelde K.H., Rittner C. J. Med. Virol. 54:173-177(1998) · Mapped (6) |
| A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. Hohler T., Kruger A., Schneider P.M., Schopf R.E., Knop J., Rittner C., Meyer zum Buschenfelde K.H., Marker-Hermann E. J. Invest. Dermatol. 109:562-565(1997) · Mapped (6) |
